Your browser doesn't support javascript.
loading
speedingCARs: accelerating the engineering of CAR T cells by signaling domain shuffling and single-cell sequencing.
Castellanos-Rueda, Rocío; Di Roberto, Raphaël B; Bieberich, Florian; Schlatter, Fabrice S; Palianina, Darya; Nguyen, Oanh T P; Kapetanovic, Edo; Läubli, Heinz; Hierlemann, Andreas; Khanna, Nina; Reddy, Sai T.
Afiliação
  • Castellanos-Rueda R; Department of Biosystems Science and Engineering, ETH Zürich, 4058, Basel, Switzerland.
  • Di Roberto RB; Life Science Zurich Graduate School, ETH Zürich, University of Zurich, 8057, Zürich, Switzerland.
  • Bieberich F; Department of Biosystems Science and Engineering, ETH Zürich, 4058, Basel, Switzerland.
  • Schlatter FS; Department of Biosystems Science and Engineering, ETH Zürich, 4058, Basel, Switzerland.
  • Palianina D; Life Science Zurich Graduate School, ETH Zürich, University of Zurich, 8057, Zürich, Switzerland.
  • Nguyen OTP; Department of Biosystems Science and Engineering, ETH Zürich, 4058, Basel, Switzerland.
  • Kapetanovic E; Department of Biomedicine, University of Basel, 4031, Basel, Switzerland.
  • Läubli H; Department of Biosystems Science and Engineering, ETH Zürich, 4058, Basel, Switzerland.
  • Hierlemann A; Department of Biosystems Science and Engineering, ETH Zürich, 4058, Basel, Switzerland.
  • Khanna N; Department of Biomedicine, University of Basel, 4031, Basel, Switzerland.
  • Reddy ST; Department of Biosystems Science and Engineering, ETH Zürich, 4058, Basel, Switzerland.
Nat Commun ; 13(1): 6555, 2022 11 02.
Article em En | MEDLINE | ID: mdl-36323661
ABSTRACT
Chimeric antigen receptors (CARs) consist of an antigen-binding region fused to intracellular signaling domains, enabling customized T cell responses against targets. Despite their major role in T cell activation, effector function and persistence, only a small set of immune signaling domains have been explored. Here we present speedingCARs, an integrated method for engineering CAR T cells via signaling domain shuffling and pooled functional screening. Leveraging the inherent modularity of natural signaling domains, we generate a library of 180 unique CAR variants genomically integrated into primary human T cells by CRISPR-Cas9. In vitro tumor cell co-culture, followed by single-cell RNA sequencing (scRNA-seq) and single-cell CAR sequencing (scCAR-seq), enables high-throughput screening for identifying several variants with tumor killing properties and T cell phenotypes markedly different from standard CARs. Mapping of the CAR scRNA-seq data onto that of tumor infiltrating lymphocytes further helps guide the selection of variants. These results thus help expand the CAR signaling domain combination space, and supports speedingCARs as a tool for the engineering of CARs for potential therapeutic development.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Receptores de Antígenos Quiméricos / Neoplasias Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Receptores de Antígenos Quiméricos / Neoplasias Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article